Gerhartz, H H <br/><br/>
Recombinant human granulocyte-macrophage colony-stimulating factor as adjunct to chemotherapy in aggressive non-Hodgkin's lymphomas.  [electronic resource] 

 -  Seminars in oncology  Dec 1994 
 - 25-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0093-7754 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Bleomycin--administration & dosage<br/>Chemotherapy, Adjuvant<br/>Cyclophosphamide--administration & dosage<br/>Disease-Free Survival<br/>Doxorubicin--administration & dosage<br/>Granulocyte-Macrophage Colony-Stimulating Factor--therapeutic use<br/>Humans<br/>Lymphoma, Non-Hodgkin--drug therapy<br/>Middle Aged<br/>Prednisone--administration & dosage<br/>Procarbazine--administration & dosage<br/>Recombinant Proteins--therapeutic use<br/>Remission Induction<br/>Vincristine--administration & dosage